Autonomic Systems Competitors

Seraph Biosciences, Inc. is a biomedical device company headquartered in Detroit, Michigan. The company was founded in 2014 with the primary purpose of commercializing its groundbreaking, diagnostic technology known as Seraspec®. Seraph's team consists of seasoned academic physicians, biomedical engineers, artificial intelligence experts, and device commercialization professionals tasked with combatting the major public health crises of our time.By leveraging the principles of Raman Spectroscopy, Seraspec® represents a paradigm shift away from current methods for screening and identification of dangerous bacterial, viral and fungal pathogens. Seraspec's® patented technology and method of detection effectively eliminates the need for time-consuming and costly laboratory-based methods of specimen collection, processing and pathogen identification. Safety, efficiency, accuracy and profitability are simultaneously enhanced through a portable, point-of-need technology for real-time pathogen detection and identification. A higher power just got involved in the fight against infection.

AdCure Bio is a pre-clinical stage cancer viro-immuno-therapy company, developing potent and safe immuno-stimulatory oncolytic viruses for therapy of solid tumors.AdCure Bio is committed to bring patients new therapies for late-stage and disseminated metastatic cancers, refractory to immunotherapy, chemotherapy and other existing treatment modalities.

TARA is dedicated to pioneering predictive cardiac tissue models that enable faster, safer, and more reliable development of new medicines. Safer and more effective new medicines that rapidly make it to market means better health and longer life, and we believe that’s great for people everywhere. TARA is focused on three critical areas. Cardiac Toxicology: TARA’s predictive tissue-based cardiac model behaves like a human heart muscle. This means that when it is employed in drug testing it can reliably identify cardiovascular complications where cell culture and animal testing models cannot; leading to a faster, safer, and less costly development process. Precision Cardiology: Every person is different and each person’s biology contains information particular only to them. TARA's platform can be used to create custom cardiac models tailored to a single person, allowing for personalized health and treatment. Heart Failure Drug Discovery: Heart failure remains a leading cause of death throughout the world. TARA's platform generates physiologically accurate diseased human tissue from stem cells; allowing for reliable testing of medicines created to treat specific heart conditions. Visit us http://tarabiosystems.com or contact us at info@tarabiosystems.com!